1 / 12

China In Vitro Diagnostics Market Forecast

Access full Research:<br><br>https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php<br><br>China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. China IVD Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products.<br>In addition; some other factors which can be attributed to China IVD market include growing prevalence of chronic lifestyle and infectious diseases, public health awareness, transformation of medical models, increasing demand of tests from the rural areas and support from the Chinese government to provide better healthcare infrastructure throughout the nation. <br><br>Request a free sample copy of the report: <br><br>https://www.renub.com/contactus.php<br><br>Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market.<br>

renubresearch
Télécharger la présentation

China In Vitro Diagnostics Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Diagnostics Market Report

  2. China IVD Market Analyst View: • China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024. Get Free Customization in this Report • Research Report Title: • China In–Vitro Diagnostics (IVD) Market, By Diagnostics (Immunoassay, Microbiology, Molecular, SMBG, POCT & etc.) & Companies • Access Full Research: • https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php

  3. China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024. China IVD Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products. In addition; some other factors which can be attributed to China IVD market include growing prevalence of chronic lifestyle and infectious diseases, public health awareness, transformation of medical models, increasing demand of tests from the rural areas and support from the Chinese government to provide better healthcare infrastructure throughout the nation.  Request a free sample copy of the report:https://www.renub.com/contactus.php

  4. China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. By Segment – Immunoassay and Clinical Chemistry dominates the China IVD Market The report studies the market of the following In–Vitro Diagnostics (IVD) segments: Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), and Point of Care Testing (POCT). Companies Analysis Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories are some of the top companies operating in the China IVD Market; which has been studied thoroughly in the report.

  5. China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024.

  6. China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. Companies Analysis Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories are some of the top companies operating in the China IVD Market; which has been studied thoroughly in the report. The report China In–Vitro Diagnostics (IVD) Market has been studied from 7 viewpoints:  1)    Market & Forecast 2)    Segment Wise Market & Forecast 3)    Development Environment & Regulatory Status in China IVD market 4)    Company-wise IVD Sales & Forecast5)    Profiles of Private Clinical Labs and Diagnostic Services6)    Growth Drivers for China In-Vitro Diagnostics7)    Challenges for China In-Vitro Diagnostics  Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php

  7. China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. This market research report provides a complete analysis of the China In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years. By Segment 1.    Clinical Chemistry 2.    Immunoassay 3.    Hematology  4.    Coagulation 5.    Microbiology  6.    Molecular Testing7.    Self Monitoring of Blood Glucose 8.    Point of Care Testing (POCT) Companies Covered in the Report: 1.    Roche Diagnostics 2.Sysmex Corporation3.Mindray Medical International Limited 4.    Abbott Laboratories 5.    Shanghai Kehua Bio-Engineering Co. Ltd. 6.    Others Profiles of Private Clinical Labs and Diagnostic Services Companies in China •    Zhejiang Di’an Diagnostics •    ADICON Clinical Laboratories•    Guangzhou Kingmed•Kindstar Global (Privately held)•    BGI-Shenzhen (Privately held) •OriGene Technologies (Privately held)

  8. Table of Contents for China In–Vitro Diagnostics Market Key Topics Covered 1. Executive Summary 2.    China IVD Market (2007 – 2024) 3.    Market Share – China In Vitro Diagnostics (IVD) (2011 – 2024) 3.1    Segments – China IVD 3.2    Companies – China IVD 4.    Segments – China IVD Market (2007 – 2024) 4.1    Clinical Chemistry Market 4.2    Immunoassay Market4.3    Hematology Market 4.4    Coagulation Market4.5    Microbiology Market 4.6    Molecular Diagnostic Market4.7    Self Monitoring of Blood Glucose (SMBG) Market4.8    Point of Care Testing (POCT) Market

  9. Table of Contents for China In–Vitro Diagnostics Market 5.    Development Environment of Chinese IVD Industry 5.1    Healthcare Reforms 5.2    Improving Quality at Grass-Root Level5.3    Embracing Technology 6.    China: Health Insurance and Reimbursement Policies 6.1    Health Insurance System 6.2    Reimbursement Rules 7.    Registration of In Vitro Diagnostic Reagents in China 7.1    Registration and Filing7.2    Filing Obligation for Clinical Trials7.3    Clinical Trial Institutions7.4    Elimination of IVD Loophole for Research7.5    Change of Manufacturing Address7.6    Change of Main Supplier of an Antigen or Antibody7.7    Update on China In-Vitro Diagnostics Registration

  10. Table of Contents for China In–Vitro Diagnostics Market 8.    Medical Devices and Reagents Class Registration in China 8.1    Process of Medical Device Registration in China8.2    Classification of In-vitro Diagnostic Reagents in China 8.3    China In-Vitro Diagnostics Reagents 9.    China IVD Industry Drivers 9.1    Increasing Demand from Middle Class for High Quality Healthcare Products9.2    Rising Incidences of Lifestyle Diseases in China9.3    Growth in Private Hospitals & Independent Diagnostic Centers 10.    China IVD Industry Challenges 10.1    Chinese Local Firms Lack of Expertise in Advanced Technology10.2    Cost Factor Restricts the Contribution of Global IVD Companies in the Chinese IVD Market10.3    Reimbursement Rates varies from Province to Province in China

  11. Table of Contents for China In–Vitro Diagnostics Market 11.    Company Sales Analysis (2011 – 2024) 11.1    Roche Diagnostics - China IVD Sales & Forecast11.2    Sysmex Corporation - China IVD Sales & Forecast11.3    Mindray Medical International Limited - China IVD Sales & Forecast11.4    Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast11.5    Abbott Laboratories - China IVD Sales & Forecast11.6    Others - China IVD Sales & Forecast 12.    Profiles of Select Private Clinical Labs and Diagnostic Services Companies 12.1    Zhejiang Di’an Diagnostics Technology Co., Ltd. 12.2    ADICON Clinical Laboratories (Privately held) 12.3    Guangzhou Kingmed Diagnostics Center Co. Ltd. 12.4    Kindstar Global (Privately held) 12.5    BGI-Shenzhen 12.6    OriGene Technologies

  12. GetFree Customization in this Report • Diagnostics Market Reports: • https://www.renub.com/diagnostics-14-c.php

More Related